Anokion raises $40 million and acquires US biotech startup

Anokion raises $40 million and acquires US biotech startup

13.9.2019 – Anokion is a Swiss biotechnology company focusing on treating autoimmune disease by restoring normal immune tolerance. The transformative transactions position the company for the next stage of growth as multiple programs advance toward clinical development.

read more on startupticker